Top-News
Verkauf, spezialisiert Schweden

Acarix News

Aktie
WKN:  A2DJR2 ISIN:  SE0009268717 US-Symbol:  ACIXF
0,017 €
-0,008 €
-32,00%
09:58:04 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website

Acarix News

22.06.22 - GlobeNewswire
Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska
Press release Malmö, Sweden, June 22, 2022
10.06.22 - GlobeNewswire
Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana.
Press release Malmö, Sweden, June 10, 2022
03.06.22 - GlobeNewswire
Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee
Press release Malmö, Sweden, June 3, 2022
11.05.22 - GlobeNewswire
Announcement from Acarix's annual general meeting
Press release Malmö, Sweden, May 11, 2022
11.05.22 - GlobeNewswire
Acarix AB (publ) publishes Interim Report, January – March 2022
Press release Malmö, Sweden, May 11, 2022
06.05.22 - GlobeNewswire
Acarix presents at Naventus Health Care Summit 2022
Press release Malmö, Sweden, May 6, 2022
20.04.22 - GlobeNewswire
Acarix publishes the annual report for 2021
Press release Malmö, Sweden, April 20, 2022
11.04.22 - GlobeNewswire
Notice of Annual General Meeting in Acarix AB
Notice of Annual General Meeting in Acarix AB
01.04.22 - GlobeNewswire
FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis
Press release (MAR) Malmö, Sweden, April 1, 2022
11.03.22 - GlobeNewswire
Acarix receives strategic order for the CADScor®System in US
Press release (MAR) Malmö, Sweden, March 11, 2022
10.03.22 - GlobeNewswire
Acarix presents at the Redeye Artificial Intelligence Seminar 2022
Press release Malmö, Sweden, March 10, 2022
17.02.22 - GlobeNewswire
Correction of press release: Acarix AB (publ) publishes Year-End Report 2021
Press release Malmö, Sweden, February 17, 2022
17.02.22 - GlobeNewswire
Acarix AB (publ) publishes Year-End Report 2021
Press release Malmö, Sweden, February 17, 2022
09.02.22 - GlobeNewswire
Acarix submits breakthrough designation request with FDA for heart failure diagnosis
Press release Malmö, Sweden, February 9, 2022
09.02.22 - GlobeNewswire
Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022
Press release Malmö, Sweden, February 9, 2022
07.02.22 - GlobeNewswire
Acarix invites to virtual Capital Market Day
Press release Malmö, Sweden, February 7, 2022
10.01.22 - GlobeNewswire
Acarix appoints US based Helen Ljungdahl Round as new CEO
Press release (MAR) Malmö, Sweden, January 10, 2022
29.12.21 - GlobeNewswire
Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue
Press release Malmö, December 29, 2021
20.12.21 - GlobeNewswire
Acarix announce final outcome in rights issue
Press release Malmö, December 20, 2021
30.11.21 - GlobeNewswire
Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million
Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Newssuche

Videos

newspaper
09:05 Uhr -2,20%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »